Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Amyris to host conference call » 16:24
04/16/21
04/16
16:24
04/16/21
16:24
AMRS

Amyris

$15.05 /

-0.66 (-4.20%)

Management holds an…

Management holds an investor update conference call on April 22 at 1 pm. Webcast Link

ShowHide Related Items >><<
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

AMRS Amyris
$15.05 /

-0.66 (-4.20%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

  • 09
    Apr
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

AMRS Amyris
$15.05 /

-0.66 (-4.20%)

Thursday
Hot Stocks
Amyris to acquire EcoFabulous Cosmetics, terms not disclosed » 08:03
04/15/21
04/15
08:03
04/15/21
08:03
AMRS

Amyris

$16.07 /

+0.71 (+4.62%)

Amyris announced that it…

Amyris announced that it has executed a binding term sheet for the acquisition of Gen Z-focused beauty brand, EcoFabulous Cosmetics. The acquisition furthers Amyris's growth and market leadership in clean beauty and complements Amyris's family of consumer brands, consisting of Biossance, Pipette, Rose Inc., JVN, Terasana, and Costa Brazil. Amyris is acquiring a 70% controlling interest in EcoFabulous and expects to grow the Gen Z consumer segment through Amyris's innovative science, sustainable ingredients, clean formulation and direct-to-consumer marketing expertise. Marissa will join Amyris to lead brand innovation and be the Chief Creative Officer for the EcoFabulous brand.

ShowHide Related Items >><<
AMRS Amyris
$16.07 /

+0.71 (+4.62%)

AMRS Amyris
$16.07 /

+0.71 (+4.62%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$16.07 /

+0.71 (+4.62%)

  • 09
    Apr
AMRS Amyris
$16.07 /

+0.71 (+4.62%)

AMRS Amyris
$16.07 /

+0.71 (+4.62%)

Wednesday
Hot Stocks
Amyris to acquire Beauty Labs, terms not disclosed » 08:02
04/14/21
04/14
08:02
04/14/21
08:02
AMRS

Amyris

$15.36 /

-0.19 (-1.22%)

Amyris announced that it…

Amyris announced that it has agreed to acquire Beauty Labs, an AI technology company that provides connected consumer experiences to the beauty and wellness community. The parties expect to sign a definitive agreement and close over the next 30 days subject to the successful completion of due diligence and customary closing conditions.

ShowHide Related Items >><<
AMRS Amyris
$15.36 /

-0.19 (-1.22%)

AMRS Amyris
$15.36 /

-0.19 (-1.22%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$15.36 /

-0.19 (-1.22%)

  • 09
    Apr
AMRS Amyris
$15.36 /

-0.19 (-1.22%)

AMRS Amyris
$15.36 /

-0.19 (-1.22%)

Over a week ago
Syndicate
Amyris 19.05M share Spot Secondary priced at $15.75 » 06:13
04/09/21
04/09
06:13
04/09/21
06:13
AMRS

Amyris

$16.04 /

-0.82 (-4.86%)

The deal size was…

The deal size was increased to $300M from $250M and priced below the last closing price of $16.04. JPMorgan and Cowen are acting as joint book running managers for the offering.

ShowHide Related Items >><<
AMRS Amyris
$16.04 /

-0.82 (-4.86%)

AMRS Amyris
$16.04 /

-0.82 (-4.86%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$16.04 /

-0.82 (-4.86%)

  • 09
    Apr
AMRS Amyris
$16.04 /

-0.82 (-4.86%)

AMRS Amyris
$16.04 /

-0.82 (-4.86%)

On The Fly
Fly Intel: Pre-market Movers » 08:59
04/08/21
04/08
08:59
04/08/21
08:59
ORBC

Orbcomm

$7.58 /

-0.24 (-3.07%)

, IMMP

Immutep

$3.20 /

+0.17 (+5.61%)

, GME

GameStop

$177.95 /

-6.24 (-3.39%)

, AVCT

AVCtechnologies

$5.81 /

-0.25 (-4.13%)

, CAG

Conagra Brands

$37.24 /

-0.365 (-0.97%)

, APOG

Apogee Enterprises

$39.50 /

-1.11 (-2.73%)

, VLO

Valero

$74.45 /

+0.3 (+0.40%)

, BOX

Box

$24.26 /

+0.15 (+0.62%)

, OTIC

Otonomy

$2.46 /

-0.11 (-4.28%)

, AMRS

Amyris

$16.87 /

-1.37 (-7.51%)

, CGC

Canopy Growth

$29.92 /

-0.97 (-3.14%)

Check out this morning's…

ShowHide Related Items >><<
VLO Valero
$74.45 /

+0.3 (+0.40%)

OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

ORBC Orbcomm
$7.58 /

-0.24 (-3.07%)

IMMP Immutep
$3.20 /

+0.17 (+5.61%)

GME GameStop
$177.95 /

-6.24 (-3.39%)

CGC Canopy Growth
$29.92 /

-0.97 (-3.14%)

CAG Conagra Brands
$37.24 /

-0.365 (-0.97%)

BOX Box
$24.26 /

+0.15 (+0.62%)

AVCT AVCtechnologies
$5.81 /

-0.25 (-4.13%)

APOG Apogee Enterprises
$39.50 /

-1.11 (-2.73%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

ORBC Orbcomm
$7.58 /

-0.24 (-3.07%)

02/25/21 Raymond James
Orbcomm price target raised to $10 from $8 at Raymond James
02/24/21 Roth Capital
Orbcomm price target raised to $9.25 from $7.50 at Roth Capital
12/21/20 Northland
Orbcomm price target raised to $10 from $6 at Northland
07/30/20 Roth Capital
Orbcomm price target raised to $7.50 from $7 at Roth Capital
IMMP Immutep
$3.20 /

+0.17 (+5.61%)

01/26/21 Alliance Global Partners
Immutep price target raised to $6 from $5 at Alliance Global Partners
12/14/20 Maxim
Maxim doubled Immutep price target after breast cancer update
11/11/20 Maxim
Immutep price target raised to $4 from $2 at Maxim
09/22/20
Top five analyst initiations
GME GameStop
$177.95 /

-6.24 (-3.39%)

04/06/21 BofA
BofA keeps $10 target on GameStop despite 'positive' funding news
04/05/21 Telsey Advisory
Telsey keeps Underperform rating on GameStop after Q1 update, ATM program bump
03/24/21
Fly Intel: Top five analyst downgrades
03/24/21 Jefferies
GameStop price target raised to $175 from $15 at Jefferies
AVCT AVCtechnologies
$5.81 /

-0.25 (-4.13%)

04/08/21 Northland
Ribbon could see 'healthy return' on Kandy if AVC sold, says Northland
CAG Conagra Brands
$37.24 /

-0.365 (-0.97%)

01/12/21 Jefferies
Conagra Brands price target lowered to $40 from $41 at Jefferies
01/08/21 Credit Suisse
Conagra Brands price target lowered to $33 from $34 at Credit Suisse
01/05/21 Credit Suisse
Conagra Brands downgraded to Underperform from Neutral at Credit Suisse
09/29/20 RBC Capital
Conagra Brands product line benefits from current environment, says RBC Capital
APOG Apogee Enterprises
$39.50 /

-1.11 (-2.73%)

12/21/20 Craig-Hallum
Apogee Enterprises price target raised to $39 from $31 at Craig-Hallum
09/18/20 DA Davidson
Apogee Enterprises price target raised to $25 from $20 at DA Davidson
VLO Valero
$74.45 /

+0.3 (+0.40%)

04/05/21 Tudor Pickering
Valero upgraded to Buy from Hold at Tudor Pickering
04/01/21 Piper Sandler
Valero price target raised to $80 from $70 at Piper Sandler
03/08/21 Barclays
Valero price target raised to $85 from $69 at Barclays
02/26/21 Mizuho
Valero price target raised to $86 from $50 at Mizuho
BOX Box
$24.26 /

+0.15 (+0.62%)

03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
03/23/21 DA Davidson
Box price target raised to $25 from $18 at DA Davidson
01/25/21
Fly Intel: Top five analyst downgrades
01/25/21 DA Davidson
Box downgraded to Neutral from Buy at DA Davidson
OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

02/22/21 Piper Sandler
Otonomy price target lowered to $5 from $10 at Piper Sandler
12/18/20 H.C. Wainwright
Otonomy price target raised to $10 from $9 at H.C. Wainwright
12/17/20 Piper Sandler
Piper says Otonomy's OTO-413 appears active, peak sales 'not accounted for'
11/04/20 Piper Sandler
Piper Sandler likes risk/reward on Otonomy ahead of two readouts by year-end
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
CGC Canopy Growth
$29.92 /

-0.97 (-3.14%)

04/08/21 Alliance Global Partners
Canopy Growth price target lowered to C$40 from C$60 at Alliance Global Partners
04/06/21 MKM Partners
Canopy Growth price target raised to C$55 from C$28 at MKM Partners
04/05/21 CIBC
Canopy Growth price target lowered to C$55 from C$64 at CIBC
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
VLO Valero
$74.45 /

+0.3 (+0.40%)

OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

ORBC Orbcomm
$7.58 /

-0.24 (-3.07%)

GME GameStop
$177.95 /

-6.24 (-3.39%)

CGC Canopy Growth
$29.92 /

-0.97 (-3.14%)

CAG Conagra Brands
$37.24 /

-0.365 (-0.97%)

BOX Box
$24.26 /

+0.15 (+0.62%)

APOG Apogee Enterprises
$39.50 /

-1.11 (-2.73%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

  • 09
    Apr
  • 08
    Apr
  • 09
    Jul
VLO Valero
$74.45 /

+0.3 (+0.40%)

GME GameStop
$177.95 /

-6.24 (-3.39%)

CGC Canopy Growth
$29.92 /

-0.97 (-3.14%)

CAG Conagra Brands
$37.24 /

-0.365 (-0.97%)

BOX Box
$24.26 /

+0.15 (+0.62%)

OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

IMMP Immutep
$3.20 /

+0.17 (+5.61%)

GME GameStop
$177.95 /

-6.24 (-3.39%)

CGC Canopy Growth
$29.92 /

-0.97 (-3.14%)

CAG Conagra Brands
$37.24 /

-0.365 (-0.97%)

BOX Box
$24.26 /

+0.15 (+0.62%)

AVCT AVCtechnologies
$5.81 /

-0.25 (-4.13%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

VLO Valero
$74.45 /

+0.3 (+0.40%)

GME GameStop
$177.95 /

-6.24 (-3.39%)

CGC Canopy Growth
$29.92 /

-0.97 (-3.14%)

BOX Box
$24.26 /

+0.15 (+0.62%)

AVCT AVCtechnologies
$5.81 /

-0.25 (-4.13%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

On The Fly
Fly Intel: After-Hours Movers » 18:56
04/07/21
04/07
18:56
04/07/21
18:56
RGP

Resources Connection

$13.63 /

-0.12 (-0.87%)

, AVCT

AVCtechnologies

$5.81 /

-0.25 (-4.13%)

, LNDC

Landec

$10.92 /

-0.2 (-1.80%)

, KDNY

Chinook Therapeutics

$14.77 /

-0.1 (-0.67%)

, AMRS

Amyris

$16.87 /

-1.37 (-7.51%)

, OTIC

Otonomy

$2.46 /

-0.11 (-4.28%)

, PRGS

Progress Software

$46.20 /

-0.6501 (-1.39%)

Check out this evening's…

ShowHide Related Items >><<
RGP Resources Connection
$13.63 /

-0.12 (-0.87%)

PRGS Progress Software
$46.20 /

-0.6501 (-1.39%)

OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

LNDC Landec
$10.92 /

-0.2 (-1.80%)

KDNY Chinook Therapeutics
$14.77 /

-0.1 (-0.67%)

AVCT AVCtechnologies
$5.81 /

-0.25 (-4.13%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

RGP Resources Connection
$13.63 /

-0.12 (-0.87%)

06/19/20 Sidoti
Resources Connection initiated with a Buy at Sidoti
AVCT AVCtechnologies
$5.81 /

-0.25 (-4.13%)

LNDC Landec
$10.92 /

-0.2 (-1.80%)

06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Lake Street
Landec price target raised to $11 after revenue beat at Lake Street
06/30/20 Barrington
Landec downgraded to Market Perform from Outperform at Barrington
04/21/20 Roth Capital
Landec upgraded to Buy from Neutral at Roth Capital
KDNY Chinook Therapeutics
$14.77 /

-0.1 (-0.67%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

02/22/21 Piper Sandler
Otonomy price target lowered to $5 from $10 at Piper Sandler
12/18/20 H.C. Wainwright
Otonomy price target raised to $10 from $9 at H.C. Wainwright
12/17/20 Piper Sandler
Piper says Otonomy's OTO-413 appears active, peak sales 'not accounted for'
11/04/20 Piper Sandler
Piper Sandler likes risk/reward on Otonomy ahead of two readouts by year-end
PRGS Progress Software
$46.20 /

-0.6501 (-1.39%)

08/26/20 Wedbush
Progress Software assumed with an Outperform at Wedbush
06/26/20 Benchmark
Progress Software price target raised to $43 from $39 at Benchmark
RGP Resources Connection
$13.63 /

-0.12 (-0.87%)

PRGS Progress Software
$46.20 /

-0.6501 (-1.39%)

OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

LNDC Landec
$10.92 /

-0.2 (-1.80%)

KDNY Chinook Therapeutics
$14.77 /

-0.1 (-0.67%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

  • 08
    Apr
  • 09
    Jul
RGP Resources Connection
$13.63 /

-0.12 (-0.87%)

PRGS Progress Software
$46.20 /

-0.6501 (-1.39%)

OTIC Otonomy
$2.46 /

-0.11 (-4.28%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

RGP Resources Connection
$13.63 /

-0.12 (-0.87%)

PRGS Progress Software
$46.20 /

-0.6501 (-1.39%)

LNDC Landec
$10.92 /

-0.2 (-1.80%)

KDNY Chinook Therapeutics
$14.77 /

-0.1 (-0.67%)

AVCT AVCtechnologies
$5.81 /

-0.25 (-4.13%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

Hot Stocks
Amyris drops 7% to $15.60 after announcing $250M common stock offering  17:59
04/07/21
04/07
17:59
04/07/21
17:59
AMRS

Amyris

$16.87 /

-1.37 (-7.51%)

 
ShowHide Related Items >><<
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

Syndicate
Amyris announces $250M offering of common stock » 17:49
04/07/21
04/07
17:49
04/07/21
17:49
AMRS

Amyris

$16.87 /

-1.37 (-7.51%)

Amyris is conducting a…

Amyris is conducting a resale of stock on behalf of its current stockholders, DSM International B.V. and affiliates of Vivo Capital LLC. The selling stockholders intend to offer an aggregate of $150M of shares of Amyris's common stock. Amyris will not receive any proceeds from the sale of the shares by the selling stockholders. Additionally, Amyris intends to offer $100M of shares of its common stock to support its continued growth. J.P. Morgan Securities and Cowen and Company are acting as the joint bookrunning managers for the proposed offering.

ShowHide Related Items >><<
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

Syndicate
Amyris files automatic mixed securities shelf  17:20
04/07/21
04/07
17:20
04/07/21
17:20
AMRS

Amyris

$16.87 /

-1.37 (-7.51%)

 
ShowHide Related Items >><<
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

AMRS Amyris
$16.87 /

-1.37 (-7.51%)

Hot Stocks
Amyris signs supply agreement with DSM Nutritional Products » 08:09
03/31/21
03/31
08:09
03/31/21
08:09
AMRS

Amyris

$20.03 /

+1.3 (+6.94%)

Amyris announced that it…

Amyris announced that it has signed and closed an agreement with DSM Nutritional Products for the exclusive rights to supply Amyris's product portfolio of flavor and fragrance ingredients. Amyris will continue to develop, scale and manufacture future molecules with its existing partners and DSM. The total transaction value is estimated at over $500M from short and long-term contributions with approximately 1/3 as an upfront payment at closing, more than 1/3 from potential earn-out payments based on milestones over the three year period from 2022 through 2024, and the remainder attributable to a 15-year manufacturing agreement between Amyris and DSM and the expected value of developing and scaling a pipeline of new F&F molecules through collaboration agreements.

ShowHide Related Items >><<
AMRS Amyris
$20.03 /

+1.3 (+6.94%)

AMRS Amyris
$20.03 /

+1.3 (+6.94%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$20.03 /

+1.3 (+6.94%)

AMRS Amyris
$20.03 /

+1.3 (+6.94%)

AMRS Amyris
$20.03 /

+1.3 (+6.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.